Midlife stroke risk and cognitive decline: A 10-year follow-up of the Whitehall II cohort study

Alzheimer's and Dementia

Volumn 9, Issue 5, 2013, Pages 572-579

  Kaffashian, Sara ^a   Dugravot, Aline ^a,b   Brunner, Eric J ^c   Sabia, Séverine ^c   Ankri, Joël ^b,d   Kivimäki, Mika ^c   Singh Manoux, Archana ^a,b,c,d  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Versailles Saint Quentin en Yvelines University   (France)

Author keywords

Aging; Cognitive decline; Framingham Stroke Risk Profile; Mid life; Vascular risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE;

AGING; COGNITIVE DECLINE; FRAMINGHAM STROKE RISK PROFILE; MID LIFE; VASCULAR RISK FACTORS;

CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COHORT STUDIES; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; STROKE;

EID: 84883555529     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.07.001     Document Type: Article

References (46)

1. D.W. Desmond, J.T. Moroney, M. Sano, and Y. Stern Incidence of dementia after ischemic stroke: results of a longitudinal study Stroke 33 2002 2254 2260 (Pubitemid 35014639)
2. A. Gamaldo, A. Moghekar, S. Kilada, S.M. Resnick, A.B. Zonderman, and R. O'Brien Effect of a clinical stroke on the risk of dementia in a prospective cohort Neurology 67 2006 1363 1369 (Pubitemid 44632058)
3. C.S. Ivan, S. Seshadri, A. Beiser, R. Au, C.S. Kase, and M. Kelly-Hayes Dementia after stroke: the Framingham Study Stroke 35 2004 1264 1268 (Pubitemid 38697439)
4. S.T. Pendlebury, and P.M. Rothwell Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis Lancet Neurol 8 2009 1006 1018
5. D. Leys, H. Henon, M.A. Mackowiak-Cordoliani, and F. Pasquier Poststroke dementia Lancet Neurol 4 2005 752 759 (Pubitemid 41457291)
6. T. Linden, I. Skoog, B. Fagerberg, B. Steen, and C. Blomstrand Cognitive impairment and dementia 20 months after stroke Neuroepidemiology 23 2004 45 52 (Pubitemid 38142272)
7. M.F. Elias, L.M. Sullivan, R.B. D'Agostino, P.K. Elias, A. Beiser, and R. Au Framingham stroke risk profile and lowered cognitive performance Stroke 35 2004 404 409 (Pubitemid 38174420)
8. S.E. Young, A.G. Mainous III, and M. Carnemolla Hyperinsulinemia and cognitive decline in a middle-aged cohort Diabetes Care 29 2006 2688 2693 (Pubitemid 44912200)
9. W.L. Xu, A.R. Atti, M. Gatz, N.L. Pedersen, B. Johansson, and L. Fratiglioni Midlife overweight and obesity increase late-life dementia risk: a population-based twin study Neurology 76 2011 1568 1574
10. R.A. Whitmer, S. Sidney, J. Selby, S.C. Johnston, and K. Yaffe Midlife cardiovascular risk factors and risk of dementia in late life Neurology 64 2005 277 281
11. S.L. Tyas, L.R. White, H. Petrovitch, R.G. Webster, D.J. Foley, and H.K. Heimovitz Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study Neurobiol Aging 24 2003 589 596 (Pubitemid 36513707)
12. J.T. O'Brien Vascular cognitive impairment Am J Geriatr Psychiatry 14 2006 724 733 (Pubitemid 44380064)
13. D. Knopman, L.L. Boland, T. Mosley, G. Howard, D. Liao, and M. Szklo Cardiovascular risk factors and cognitive decline in middle-aged adults Neurology 56 2001 42 48 (Pubitemid 32059650)
14. M. Kivipelto, E.L. Helkala, T. Hanninen, M.P. Laakso, M. Hallikainen, and K. Alhainen Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study Neurology 56 2001 1683 1689 (Pubitemid 32574567)
15. M. Kivipelto, E.L. Helkala, M.P. Laakso, T. Hanninen, M. Hallikainen, and K. Alhainen Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study BMJ 322 2001 1447 1451 (Pubitemid 32575406)
16. M. Kivipelto, T. Ngandu, L. Fratiglioni, M. Viitanen, I. Kareholt, and B. Winblad Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease Arch Neurol 62 2005 1556 1560 (Pubitemid 41434560)
17. S. Debette, S. Seshadri, A. Beiser, R. Au, J.J. Himali, and C. Palumbo Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline Neurology 77 2011 461 468
18. A. Hofman, A. Ott, M.M. Breteler, M.L. Bots, A.J. Slooter, and H.F. van Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study Lancet 349 1997 151 154 (Pubitemid 27039193)
19. V. Hachinski The 2005 Thomas Willis Lecture: stroke and vascular cognitive impairment: a transdisciplinary, translational and transactional approach Stroke 38 2007 1396
20. V. Hachinski Shifts in thinking about dementia JAMA 300 2008 2172 2173
21. F.W. Unverzagt, L.A. McClure, V.G. Wadley, N.S. Jenny, R.C. Go, and M. Cushman Vascular risk factors and cognitive impairment in a stroke-free cohort Neurology 77 2011 1729 1736
22. D.J. Llewellyn, I.A. Lang, J. Xie, F.A. Huppert, D. Melzer, and K.M. Langa Framingham Stroke Risk Profile and poor cognitive function: a population-based study BMC Neurol 8 2008 12
23. S. Seshadri, P.A. Wolf, A. Beiser, M.F. Elias, R. Au, and C.S. Kase Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study Neurology 63 2004 1591 1599 (Pubitemid 39507574)
24. C.B. Brady, A. Spiro, R. McGlinchey-Berroth, W. Milberg, and J.M. Gaziano Stroke risk predicts verbal fluency decline in healthy older men: evidence from the normative aging study J Gerontol B Psychol Sci Soc Sci 56 2001 340 346
25. M. Marmot, and E. Brunner Cohort profile: the Whitehall II study Int J Epidemiol 34 2005 251 256 (Pubitemid 40645308)
26. R.B. D'Agostino, P.A. Wolf, A.J. Belanger, and W.B. Kannel Stroke risk profile: adjustment for antihypertensive medication: the Framingham Study Stroke 25 1994 40 43
27. P.A. Wolf, R.B. D'Agostino, A.J. Belanger, and W.B. Kannel Probability of stroke: a risk profile from the Framingham Study Stroke 22 1991 312 318
28. M. Kivimaki, M.J. Shipley, C.L. Allan, C.E. Sexton, M. Jokela, and M. Virtanen Vascular risk status as a predictor of later-life depressive symptoms: a cohort study Biol Psychiatry 72 2012 324 333
29. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 26 2003 S5 S20
30. A. Singh-Manoux, M. Kivimaki, M.M. Glymour, A. Elbaz, C. Berr, and K.P. Ebmeier Timing of onset of cognitive decline: results from Whitehall II prospective cohort study BMJ 344 2012 d7622
31. A.W. Heim AH4: group test of general intelligence 1970 NFER-Nelson Publishing Company Windsor, UK
32. J.G. Borkowski, A.L. Benton, and O. Spreen Word fluency and brain damage Neuropsychologica 5 1967 135 140
33. J.C. Raven Guide to using the Mill Hill vocabulary test with progressive matrices 1965 HK Lewis London, UK
34. A. Singh-Manoux, T.N. Akbaraly, M. Marmot, M. Melchior, J. Ankri, and S. Sabia Persistent depressive symptoms and cognitive function in late midlife: the Whitehall II study J Clin Psychiatry 71 2010 1379 1385
35. S. Sabia, H. Nabi, M. Kivimaki, M.J. Shipley, M.G. Marmot, and A. Singh-Manoux Health behaviors from early to late midlife as predictors of cognitive function: the Whitehall II study Am J Epidemiol 170 2009 428 437
36. D.S. Knopman, T.H. Mosley, D.J. Catellier, and L.H. Coker Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI study Alzheimers Dement 5 2009 207 214
37. J.A. Luchsinger, C. Reitz, B. Patel, M.X. Tang, J.J. Manly, and R. Mayeux Relation of diabetes to mild cognitive impairment Arch Neurol 64 2007 570 575 (Pubitemid 46588347)
38. E.M. Schrijvers, J.C. Witteman, E.J. Sijbrands, A. Hofman, P.J. Koudstaal, and M.M. Breteler Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study Neurology 75 2010 1982 1987
39. D.S. Knopman, A.D. Penman, D.J. Catellier, L.H. Coker, D.K. Shibata, and A.R. Sharrett Vascular risk factors and longitudinal changes on brain MRI: the ARIC study Neurology 76 2011 1879 1885
40. J.V. Bowler Criteria for vascular dementia: replacing dogma with data Arch Neurol 57 2000 170 171 (Pubitemid 30097182)
41. N.A. Phillips, and C.C. Mate-Kole Cognitive deficits in peripheral vascular disease: a comparison of mild stroke patients and normal control subjects Stroke 28 1997 777 784 (Pubitemid 27161463)
42. S. Debette, A. Beiser, C. DeCarli, R. Au, J.J. Himali, and M. Kelly-Hayes Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study Stroke 41 2010 600 606
43. S.E. Vermeer, N.D. Prins, H.T. den, A. Hofman, P.J. Koudstaal, and M.M. Breteler Silent brain infarcts and the risk of dementia and cognitive decline N Engl J Med 348 2003 1215 1222 (Pubitemid 36359297)
44. J.C. de Groot, F.E. de Leeuw, M. Oudkerk, G.J. Van, A. Hofman, and J. Jolles Periventricular cerebral white matter lesions predict rate of cognitive decline Ann Neurol 52 2002 335 341 (Pubitemid 35001500)
45. M.F. Elias, A. Beiser, P.A. Wolf, R. Au, R.F. White, and R.B. D'Agostino The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort Arch Neurol 57 2000 808 813 (Pubitemid 30397182)
46. D.E. Barnes, and K. Yaffe The projected effect of risk factor reduction on Alzheimer's disease prevalence Lancet Neurol 10 2011 819 828